Design and validation of an ELISA for equine infectious anemia (EIA) diagnosis using synthetic peptides.

This research article discusses the development and validation of an Enzyme-Linked ImmunoSorbent Assay (ELISA) based on synthetic peptides for diagnosing equine infectious anemia (EIA). Comparing its sensitivity to the conventional agar gel immunodiffusion (AGID) test, the improved ELISA effectively distinguishes positive and negative samples, and it can facilitate a large-scale and accurate diagnosis in areas with varying prevalences of EIA.

Introduction to the ELISA and EIA

• Elisa is a common biochemical test that involves the binding of a known antigen to an antibody to detect the presence of the antigen.
• Equine Infectious Anemia (EIA) is a contagious disease affecting horses, caused by a retrovirus that breaches the immune system leading to acute, chronic, or inapparent manifestations in the horses.

Peptides Derived from Surface Proteins of EIAV

• The researchers synthesized three different peptides from the surface proteins of the Equine Infectious Anemia Virus (EIAV).
• Two of these peptides, gp90-I and gp90-II, are representative of the N- and C-terminal parts of the EIAV surface glycoprotein gp90, while the third peptide, gp45-1, overlaps with an essentially significant epitope of the transmembrane glycoprotein gp45.
• This last peptide also includes a hydrophilic chain close to the N-terminal end of the nonapeptide loop, presumably enhancing its reactivity.

Sample Selection and Testing

• To validate the assay, the researchers used serum samples from 140 horses naturally infected with EIAV and a control sample of 167 equine sera from non-infected animals.
• The reactivity gap between positive and negative serum samples was clearly visible, showing the effectiveness of the improved ELISA.
• Particularly, samples that were categorized as weakly positive in the AGID test came out as clearly positive in the new ELISA test, demonstrating its superior sensitivity.

Analysis and Findings

• In the study, the cyclic peptide corresponding to the immunodominant sequence of gp45 was observed to react excellently. The researchers concluded that functionality depended greatly on the conformation of the peptide given that the linear form showed little reactivity.
• The detection indices of positive and negative sera using this new ELISA reached 98% when both gp90-II and gp45-I synthetic peptides were incorporated in the assay. This illustrates the high specificity and sensitivity of the ELISA.

Significance of the Study

• This study presents a significant step towards developing a diagnostic kit that can quickly analyze large numbers of serum samples from horses. This shows potential for application, especially in areas where EIA is endemic, and prevalence varies.
• The methods developed could also be beneficial for diagnosing other diseases where similar antigen-antibody interactions occur.